Matches in SemOpenAlex for { <https://semopenalex.org/work/W2928492303> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2928492303 endingPage "174" @default.
- W2928492303 startingPage "166" @default.
- W2928492303 abstract "Background: Current guidelines recommend the use of vancomycin for the initial treatment of moderate to severe Clostridioides difficile Infection (CDI). Surotomycin, a novel antibiotic, has been utilized for the management of CDI with variable results. Methods: A systematic literature search was performed using the following electronic databases [Medline, Embase, google scholar and Cochrane] for eligible studies. Randomized controlled trials comparing Surotomycin with Vancomycin for the CDI treatment were included. Demographic variables and outcomes (CDI resolution, CDI recurrence, B1/NAP1/027-specific strain treatment, B1/NAP1/027-strain recurrence, death not related to treatment) were analyzed. The primary outcome was clinical cure rate defined as the resolution of CDI at the end of the 10-day drug course. Results: Three RCTs met the inclusion criteria with a total of 1280 patients with CDI who received either surotomycin 250 mg twice daily (642 patients) or vancomycin 125 mg four times daily (638 patients). Clinical cure rates after 10 days of treatment with either surotomycin or vancomycin were not significantly different (pooled OR: 0.89, 95% CI 0.66-1.18, p=0.41). Sustained clinical response at clinical follow-up and the overall recurrence of CDI were also not significantly different between the two groups – pooled OR 1.15 (95% CI 0.89-1.50, p=0.29) and pooled OR 0.74 (95%CI 0.52- 1.04, p=0.08), respectively. With regards to the NAP1/BI/027 strain, patients in the surotomycin group had significantly lower rates of recurrence compared to vancomycin (pooled OR 0.35, 95% CI 0.19-0.63, p<0.01). Conclusion: Surotomycin is non-inferior to vancomycin and offers a promising alternative for the treatment and prevention of C. diff infection." @default.
- W2928492303 created "2019-04-11" @default.
- W2928492303 creator A5000645928 @default.
- W2928492303 creator A5027610705 @default.
- W2928492303 creator A5051544870 @default.
- W2928492303 creator A5068248035 @default.
- W2928492303 creator A5085827064 @default.
- W2928492303 creator A5086339007 @default.
- W2928492303 creator A5086384156 @default.
- W2928492303 date "2019-12-31" @default.
- W2928492303 modified "2023-09-27" @default.
- W2928492303 title "Surotomycin (A Novel Cyclic Lipopeptide) vs. Vancomycin for the Treatment of Clostridioides difficile Infection: A Systematic Review and Meta-analysis" @default.
- W2928492303 cites W1943950351 @default.
- W2928492303 cites W2048866421 @default.
- W2928492303 cites W2049355215 @default.
- W2928492303 cites W2075288664 @default.
- W2928492303 cites W2098923148 @default.
- W2928492303 cites W2113556993 @default.
- W2928492303 cites W2125435699 @default.
- W2928492303 cites W2131038214 @default.
- W2928492303 cites W2149642295 @default.
- W2928492303 cites W2153534612 @default.
- W2928492303 cites W2154900496 @default.
- W2928492303 cites W2399278318 @default.
- W2928492303 cites W2501981640 @default.
- W2928492303 cites W2588484778 @default.
- W2928492303 cites W2752378836 @default.
- W2928492303 cites W2781567656 @default.
- W2928492303 cites W2791326569 @default.
- W2928492303 cites W2807795538 @default.
- W2928492303 cites W2911779456 @default.
- W2928492303 doi "https://doi.org/10.2174/1574884714666190328162637" @default.
- W2928492303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30924421" @default.
- W2928492303 hasPublicationYear "2019" @default.
- W2928492303 type Work @default.
- W2928492303 sameAs 2928492303 @default.
- W2928492303 citedByCount "5" @default.
- W2928492303 countsByYear W29284923032019 @default.
- W2928492303 countsByYear W29284923032020 @default.
- W2928492303 countsByYear W29284923032023 @default.
- W2928492303 crossrefType "journal-article" @default.
- W2928492303 hasAuthorship W2928492303A5000645928 @default.
- W2928492303 hasAuthorship W2928492303A5027610705 @default.
- W2928492303 hasAuthorship W2928492303A5051544870 @default.
- W2928492303 hasAuthorship W2928492303A5068248035 @default.
- W2928492303 hasAuthorship W2928492303A5085827064 @default.
- W2928492303 hasAuthorship W2928492303A5086339007 @default.
- W2928492303 hasAuthorship W2928492303A5086384156 @default.
- W2928492303 hasConcept C126322002 @default.
- W2928492303 hasConcept C141071460 @default.
- W2928492303 hasConcept C168563851 @default.
- W2928492303 hasConcept C2776478404 @default.
- W2928492303 hasConcept C2778980435 @default.
- W2928492303 hasConcept C2779489039 @default.
- W2928492303 hasConcept C2910067853 @default.
- W2928492303 hasConcept C501593827 @default.
- W2928492303 hasConcept C523546767 @default.
- W2928492303 hasConcept C54355233 @default.
- W2928492303 hasConcept C71924100 @default.
- W2928492303 hasConcept C86803240 @default.
- W2928492303 hasConcept C89423630 @default.
- W2928492303 hasConcept C90924648 @default.
- W2928492303 hasConcept C95190672 @default.
- W2928492303 hasConceptScore W2928492303C126322002 @default.
- W2928492303 hasConceptScore W2928492303C141071460 @default.
- W2928492303 hasConceptScore W2928492303C168563851 @default.
- W2928492303 hasConceptScore W2928492303C2776478404 @default.
- W2928492303 hasConceptScore W2928492303C2778980435 @default.
- W2928492303 hasConceptScore W2928492303C2779489039 @default.
- W2928492303 hasConceptScore W2928492303C2910067853 @default.
- W2928492303 hasConceptScore W2928492303C501593827 @default.
- W2928492303 hasConceptScore W2928492303C523546767 @default.
- W2928492303 hasConceptScore W2928492303C54355233 @default.
- W2928492303 hasConceptScore W2928492303C71924100 @default.
- W2928492303 hasConceptScore W2928492303C86803240 @default.
- W2928492303 hasConceptScore W2928492303C89423630 @default.
- W2928492303 hasConceptScore W2928492303C90924648 @default.
- W2928492303 hasConceptScore W2928492303C95190672 @default.
- W2928492303 hasIssue "3" @default.
- W2928492303 hasLocation W29284923031 @default.
- W2928492303 hasLocation W29284923032 @default.
- W2928492303 hasOpenAccess W2928492303 @default.
- W2928492303 hasPrimaryLocation W29284923031 @default.
- W2928492303 hasRelatedWork W2381982637 @default.
- W2928492303 hasRelatedWork W2914141471 @default.
- W2928492303 hasRelatedWork W3013041320 @default.
- W2928492303 hasRelatedWork W3096683796 @default.
- W2928492303 hasRelatedWork W3132173363 @default.
- W2928492303 hasRelatedWork W3152374296 @default.
- W2928492303 hasRelatedWork W4207070666 @default.
- W2928492303 hasRelatedWork W4282969708 @default.
- W2928492303 hasRelatedWork W4292248146 @default.
- W2928492303 hasRelatedWork W4385751578 @default.
- W2928492303 hasVolume "14" @default.
- W2928492303 isParatext "false" @default.
- W2928492303 isRetracted "false" @default.
- W2928492303 magId "2928492303" @default.
- W2928492303 workType "article" @default.